Virobay Company
Virobay develops small molecule, antiviral drug treatments for autoimmune diseases, neuropathic pain, liver diseases, and cancer.
Technology:
Biologics
Industry:
PharmTech
Headquarters:
Menlo Park, California, United States
Founded Date:
2006
Employees Number:
1-10
Funding Status:
IPO
Estimated Revenue:
$1M to $10M
Register and Claim Ownership